Recent Police Force News:
Related Videos:
Scientific and Business Leaders to Discuss Challenges Facing Developers of Pain Therapeutics at Arrowhead’s 4th Annual Pain Therapeutics Summit
Now in its 4th year, Arrowhead's Annual Pain Therapeutics Summit continues to attract both academic and industry leaders from around the globe to discuss pain management, preclinical and clinical development of new pain therapeutics.
Ryogen is Awarded Patents on Two Human Genes
Ryogen LLC is awarded two U.S. Patent Nos. 7,468,266, titled "Isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2," and 7,470,522 , titled "Isolated genomic polynucleotide fragments encoding human resistin and the human syntaxin binding protein 2.
Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhase®HL – High Loaded Solid Support for Oligonucleotide S
NittoPhase® HL Loaded up to 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields
Global Market for Hepatitis C Virus Therapeutics to Reach $9.1 billion by 2015, According to New Report by Global Industry Analysts
The HCV therapeutic development landscape continues to inflate and currently possesses three compounds in Phase III clinical studies, several novel therapies in Phase II and Phase I pipeline, and numerous new compounds in animal-stage study and research stages. Driven by the new drug launches, the global HCV therapeutics market is forecast to reach $9.1 billion by 2015.
Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Successful Development of NittoPhase™ HL High Loading Solid Support for Oligon
NittoPhase™ HL Loaded up to 400umol/g delivers Market Leading Economies to Reduce Synthesis Costs and Increase Yields
Scholarship Honours York University Chemistry Professor
Peter Pekos, president and CEO of Dalton Pharma Services, has established a new scholarship to benefit chemistry students at York University in Toronto, in honour of his former mentor and business partner, Dr. Douglas Butler.
Arrowhead Publishers Releases New Report Analyzing the Global Cancer Therapy Market
A New report from Arrowhead Publishers entitled Cancer Therapeutics: Market Insight and R&D Pipeline Analysis provides valuable insight into the global market for cancer therapies and developmental-stage therapies.
Global Multiple Sclerosis Therapeutics Market to Exceed $12.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Multiple Sclerosis market. The world market for multiple sclerosis therapeutics is projected to exceed $12.5 billion by the year 2015. With prevalence of the disease growing and presence of high-unmet need, demand for innovative and improved therapeutics to treat multiple sclerosis is increasing, presenting greater prospects for market growth.
cordblood.asia
antisensedrugs.com
The antisense drug resource
adultstemcell.org
The adult stem cell forum
bionews.org
drugengineering.com